Orders of three C-RAD systems to clinics in Germany

The Catalyst system is based on a new generation hardware and software platform for high performance optical surface scanning and augmented reality through re-projection. Advanced and highly optimized algorithms for non-rigid registration and deformable models enable real-time assessment of patient positioning errors before and during treatment delivery. The system calculates isocenter adjustments and interfaces to major vendors ensure a completely integrated workflow. The C-RAD Sentinel system, based on laser technology, is offering advanced functionality for 4DCT.

One Catalyst system and one Sentinel system has been ordered by the radiation therapy clinic in Gelsenkirchen. The systems are equipped with advanced functionalities for respiratory gating and positioning of patients.

One Catalyst system has been ordered by the University hospital in Mannheim. The system is equipped with functionalities for positioning, monitoring and respiratory gating based on breath hold. The University hospital in Mannheim is an important reference site for Elekta.

As part of a cooperation the clinic is performing a study comparing data from cone beam CT and C-RAD Catalyst. A report will be published in 2013.

Erik Hedlund, CEO, C-RAD AB:

”  The two new orders from clinics in Germany are a result of the decision to establish direct sales and support to customers in Germany. Important is also the new agreement and cooperation with Elekta.

The linacs will be equipped with Elekta response 2 interfaces.”

About C-RAD

C-RAD develops new and innovative solutions for the use in advanced radiation therapy. The company group of C-RAD offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. C-RAD Imaging AB is located in Östersund while the other companies are located in Uppsala. Numbers of employees are currently 21 people. The activities in C-RAD AB originate from research and development at the Karolinska Institutet in Solna. Sales of the company’s first product, the C-RAD Sentinel^TM, started in 2007. Cooperation agreements have been signed with the Swedish company Elekta, the US company Varian  and the Belgian company IBA. C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD has founded three companies for direct sales, C-RAD Incorporated in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. C-RAD has acquired 29 % of the laser company Cyrpa and with an option to acquire the remaining 71 %. C-RAD AB is since March 2010 listed at Nasdaq Omx First North Premier.

For more information on C-RAD, please visit www.c-rad.com.

For further information:

Erik Hedlund, CEO C-RAD AB, Phone +46-18-666931, E-mail erik.hedlund@c-rad.se